Se-natal 19 Chewable Tablet, Chewable
NDC Package 13925-117-01
Package Information
Se-natal 19 Chewable (vitamins and minerals) tablets is se-Natal 19 Chewable Tablets are indicated for use in improving the nutritional status of women throughout pregnancy and in the postnatal period for both lactating and non-lactating mothers. This formulation utilizes a tablet, chewable delivery system. Marketed by Seton Pharmaceuticals, this product is identified by NDC 13925-117.
Identification & Billing
Clinical Specifications
- FOLIC ACID 30 [iU]/1
- .BETA.-CAROTENE 1000 [iU]/1
- CALCIUM ASCORBATE 100 mg/1
- CHOLECALCIFEROL 200 mg/1
- .ALPHA.-TOCOPHEROL ACETATE, DL- 7 mg/1
- THIAMINE MONONITRATE 400 [iU]/1
- RIBOFLAVIN 12 ug/1
- NIACINAMIDE 29 mg/1
- PYRIDOXINE HYDROCHLORIDE 1 mg/1
- CYANOCOBALAMIN 15 mg/1
- CALCIUM PANTOTHENATE 20 mg/1
- CALCIUM CARBONATE 3 mg/1
- FERROUS FUMARATE 3 mg/1
- ZINC OXIDE 20 mg/1
- Analogs/Derivatives - [Chemical/Ingredient]
- Ascorbic Acid - [CS]
- Blood Coagulation Factor - [EPC] (Established Pharmacologic Class)
- Calcium - [CS]
- Cations, Divalent - [CS]
- Copper Absorption Inhibitor - [EPC] (Established Pharmacologic Class)
- Decreased Copper Ion Absorption - [PE] (Physiologic Effect)
- Increased Coagulation Factor Activity - [PE] (Physiologic Effect)
- Phosphate Binder - [EPC] (Established Pharmacologic Class)
- Phosphate Chelating Activity - [MoA] (Mechanism of Action)
- Vitamin B 12 - [CS]
- Vitamin B 6 - [Chemical/Ingredient]
- Vitamin B12 - [EPC] (Established Pharmacologic Class)
- Vitamin B6 Analog - [EPC] (Established Pharmacologic Class)
- Vitamin C - [EPC] (Established Pharmacologic Class)
- Vitamin D - [CS]
- Vitamin D - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 13925 - Seton Pharmaceuticals
- 13925-117 - Se-natal 19 Chewable
- 13925-117-01 - 100 TABLET, CHEWABLE in 1 BOTTLE
- 13925-117 - Se-natal 19 Chewable
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 13925-117-01 identifies a specific commercial package of 100 tablet, chewable in 1 bottle of Se-natal 19 Chewable, a human prescription drug labeled by Seton Pharmaceuticals. This tablet, chewable is formulated for oral use and contains folic acid; .beta.-carotene; calcium ascorbate; cholecalciferol; .alpha.-tocopherol acetate, dl-; thiamine mononitrate; riboflavin; niacinamide; pyridoxine hydrochloride; cyanocobalamin; calcium pantothenate; calcium carbonate; ferrous fumarate; zinc oxide as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Seton Pharmaceuticals on July 01, 2009. The current certification is valid through December 31, 2026.
How is this Seton Pharmaceuticals product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 13925011701. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.